Chief Medical Officer Robert Kim Sells Shares of 4D Molecular Therapeutics Inc [Yahoo! Finance]
4D Molecular Therapeutics, Inc. (FDMT)
Company Research
Source: Yahoo! Finance
SEC Filing . Over the past year, the insider has sold a total of 24,552 shares and has not made any purchases of the company's stock. Warning! GuruFocus has detected 5 Warning Signs with FDMT. 4D Molecular Therapeutics Inc is a clinical-stage gene therapy company harnessing the power of directed evolution for targeted genetic medicines. The company designs and develops transformative gene therapeutic products for serious unmet medical conditions. The insider transaction history for 4D Molecular Therapeutics Inc shows a pattern of insider activity. Over the past year, there has been only 1 insider buy, while there have been 8 insider sells in the same timeframe. On the day of the insider's recent transaction, shares of 4D Molecular Therapeutics Inc were trading at $30.05, giving the company a market capitalization of $1.207 billion. The stock's price-to-GF-Value ratio stands at 1.36, with a GF Value of $22.13, indicating that 4D Molecular Therapeutics Inc is considered modest
Show less
Read more
Impact Snapshot
Event Time:
FDMT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FDMT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FDMT alerts
High impacting 4D Molecular Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
FDMT
News
- 4D Molecular Therapeutics, Inc. (FDMT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release [Yahoo! Finance]Yahoo! Finance
- 4DMT Announces Presentations at ARVO 2024 Annual Meeting [Yahoo! Finance]Yahoo! Finance
- 4DMT Announces Presentations at ARVO 2024 Annual MeetingGlobeNewswire
- 4D Molecular Therapeutics: Catalysts With Pioneering Gene Therapy With Directed Evolution [Seeking Alpha]Seeking Alpha
- Ophthalmics Collaboration and Licensing Deals Collection, 2019-2024: Leading Deals by Value, Most Active Dealmakers, Benchmark Analysis, Financial Terms, and More [Yahoo! Finance]Yahoo! Finance
FDMT
Earnings
- 11/9/23 - Beat
FDMT
Sec Filings
- 4/18/24 - Form 4
- 4/10/24 - Form ARS
- 4/10/24 - Form DEFA14A
- FDMT's page on the SEC website